In clinical studies, IgG-based tests had higher diagnostic sensitivity while IgA anti-gliadin peptide antibodies were associated with higher accuracy (Rashtak et al. 2008) and with very high values in young children with CeD (Vriezinga et al. 2014). Here, CD79A is linked to cranioectodermal dysplasia.